Bayer researchers build customized protein molecules for the treatment of serious diseases
Talent scouts: Alexander Korseska and Nina Habrich (left to right) use robots to test up to 80,000 protein variants every day.
As medicinal products, antibodies offer real hope to patients. They have a very specific effect on the disease process and help in the fight against cancer or multiple sclerosis. The protein substances - also known as biologics - act against intruders almost like the body’s own police force.
Training program for proteins
Each protein molecule attacks only one very specific target. For example, it only attacks a patient’s cancer cell receptors, not healthy tissue. Researchers at Bayer HealthCare are using high throughput technologies to optimize the structure of therapeutic proteins. Read here how they customize the substances to obtain the desired therapeutic properties.